XML 34 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Interim Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 6 Months Ended 190 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Revenue $ 0 $ 0 $ 0 $ 0 $ 0
Operating expenses:          
Research and development 860 234 1,157 549 68,250
Impairment of capital assets 0 0 0 0 386
Gain on deferred lease inducements 0 0 0 0 (497)
Acquired in-process research and development 0 0 0 0 13,094
General and administrative 390 338 710 1,044 31,259
Total operating expenses 1,250 572 1,867 1,593 112,492
Loss from operations (1,250) (572) (1,867) (1,593) (112,492)
Other income (expense):          
Settlement of Cadherin litigation 0 0 0 0 (1,283)
Interest expense 0 0 0 0 (19)
Unrealized/realized gain on derivatives 645 225 3,971 5,905 8,792
Other income 0 0 0 0 264
Interest income (loss) and other 3 (1) 8 9 2,880
Total other income (expense), net 648 224 3,979 5,914 10,634
Net (loss)/income and total comprehensive (loss)/income $ (602) $ (348) $ 2,112 $ 4,321 $ (101,858)
Basic and diluted net (loss)/income per common share $ (0.02) $ (0.01) $ 0.08 $ 0.17  
Weighted-average number of common shares outstanding, basic 25,158 25,158 25,158 25,158  
Weighted-average common shares outstanding, diluted 25,158 25,158 25,158 25,158